Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents

The aims of this study were to identify prognostic variables for toxicity and survival in patients with cancer participating in phase I clinical trials and compare characteristics of those treated with cytotoxic chemotherapy (CT) and non-cytotoxic drugs (non-CT). Data were collected from 420 (114 CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, C, Braybrooke, J P, Deplanque, G, Taylor, M, Mackintosh, D, Kaur, K, Samouri, K, Ganesan, T S, Harris, A L, Talbot, D C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394292/
https://www.ncbi.nlm.nih.gov/pubmed/14520440
http://dx.doi.org/10.1038/sj.bjc.6601218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394292/
https://www.ncbi.nlm.nih.gov/pubmed/14520440
http://dx.doi.org/10.1038/sj.bjc.6601218

Ejemplares similares